The Effects of Whey, Rice and Potato pRotein isOlates on appeTite rEgulatIoN in Healthy Men

Appetite and General Nutritional Disorders Clinical Trial

— PROTEIN  

Official title:

Comparative Effects of Dairy and Plant-based Protein Intake on Acute Glucose Homeostasis and Appetite Regulation in Healthy Men

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04876495
• Other study ID #: VRE1516-1375
• Status: Completed
• Phase: N/A
• Start date: July 20, 2018
• Est. completion date: February 19, 2021

Study information

• Verified date: May 2021
• Source: University of Westminster
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

INTRODUCTION: Global protein consumption has been increasing for decades due to changes in socio-economic demographics and consumer trends towards higher protein intake, which may be related to their health benefits in performance nutrition and appetite regulation. The additional intake of protein often occurs in the form of supplements. One of the main ingredients used in sports and weight loss supplements are animal-derived proteins such as whey, which are of high quality, containing all the essential amino acids required in human nutrition with a high absorption rate. However, whey protein has a high environmental footprint, and it may contribute to insulin resistance in susceptible groups (e.g. obese, T2DM, insulin resistant, or those with sarcopenic obesity).

Rice and potato protein isolates are high-quality plant proteins containing all essential amino acids comparably to whey protein. These plant-derived proteins may provide a more sustainable and accessible alternative to animal-derived proteins for appetite regulation and weight management.

Description:

Intervention study with three treatment groups in a randomised, single-blind, triple crossover design.

Study population: Healthy male participants will receive three different isocaloric and -volumetric protein shakes prepared using whey, rice and potato protein powders on different trial days with at least a one-week washout period apart.

Biological samples (blood and saliva samples) are collected at various time points during the visit. Blood samples are collected at baseline 10 min prior (T-10), then at 30 min (T30), 60 min (T60), 120 min (T120) and at 180 min (T180) after protein shake consumption. Saliva samples are collected at baseline (T-10), then at every 30 minutes following protein shake consumption (T30, T60, T90, T120, T150, T180). In addition, pertinent questionnaires Visual Analogue Scale [VAS] for the assessment of satiety and VAS for the assessment of protein shakes' perception will be collected at T-10, T30, T60, T90, T120, T150, T180 and at T0, respectively

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: February 19, 2021
• Est. primary completion date: February 19, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Males (18-65 years of age)

• Healthy subjects

Exclusion Criteria:

• <18 years or >65 years

• Consumption of >21 units of alcohol/week

• Dieters

• Any allergies/health issues related to items being ingested

• Any serious illnesses or those on medication

• Any illness affecting taste or appetite

• Any gastrointestinal disorders

• Any eating disorders

• Any depression/mental disorders

• Smoking

Related Conditions & MeSH terms

• Appetite and General Nutritional Disorders
• Nutrition Disorders

Intervention

Dietary Supplement:
• Whey protein isolate
Instantized BiPRO® 50g (equiv. 45.5g of total protein) presented to participants in a form of a shake. Other ingredients in the whey protein shake: Tropicana Trop50 Orange Juice 207mL Water 43 mL Sucralose 0.5g The total energy 233.47Kcal. Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.
• Potato protein isolate
Solanic®100 48g (equiv. 45.3g of total protein) presented to participants in a form of a shake. Other ingredients in the potato protein shake: Tropicana Trop50 Orange Juice 250mL Sucralose 0.5g The total energy 233.46Kcal Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.
• Rice protein isolate
Oryzatein® Silk 90 50g (equiv. 45.5g of total protein) presented to participants in a form of a shake. Other ingredients in the rice protein shake: Tropicana Trop50 Orange Juice 183mL Water 67mL Sucralose 0.5g The total energy 233.43Kcal Participants instructed to consume the entire protein shake presented to them in 5 minutes on an empty stomach when attending the study.

Locations

Country	Name	City	State
United Kingdom	University of Westminster	London	Greater London

Sponsors (2)

Lead Sponsor	Collaborator
University of Westminster	Coventry University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T-10)	Marker: glucose (mmol/L)	Glucose measured 10 minutes prior to protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T30)	Marker: glucose (mmol/L)	Glucose measured 30 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T60)	Marker: glucose (mmol/L)	Glucose measured 60 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T120)	Marker: glucose (mmol/L)	Glucose measured 120 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucose levels (T180)	Marker: glucose (mmol/L)	Glucose measured 180 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T-10)	Marker: insulin (ng/mL)	Insulin measured 10 minutes prior to protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T30)	Marker: insulin (ng/mL)	Insulin measured 30 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T60)	Marker: insulin (ng/mL)	Insulin measured 60 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T120)	Marker: insulin (ng/mL)	Insulin measured 120 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on insulin levels (T180)	Marker: insulin (ng/mL)	Insulin measured 180 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T-10)	Markers: glucagon-like peptide 1 (pM)	Glucagon-like peptide 1 measured 10 minutes prior to protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T30)	Markers: glucagon-like peptide 1 (pM)	Glucagon-like peptide 1 measured 30 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T60)	Markers: glucagon-like peptide 1 (pM)	Glucagon-like peptide 1 measured 60 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T120)	Markers: glucagon-like peptide 1 (pM)	Glucagon-like peptide 1 measured 120 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on glucagon-like peptide 1 levels (T180)	Markers: glucagon-like peptide 1 (pM)	Glucagon-like peptide 1 measured 180 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T-10)	Markers: peptide tyrosine tyrosine (pg/mL)	Peptide tyrosine tyrosine measured 10 minutes prior to protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T30)	Markers: peptide tyrosine tyrosine (pg/mL)	Peptide tyrosine tyrosine measured 30 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T60)	Markers: peptide tyrosine tyrosine (pg/mL)	Peptide tyrosine tyrosine measured 60 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T120)	Markers: peptide tyrosine tyrosine (pg/mL)	Peptide tyrosine tyrosine measured 120 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on peptide tyrosine tyrosine levels (T180)	Markers: peptide tyrosine tyrosine (pg/mL)	Peptide tyrosine tyrosine measured 180 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T-10)	Markers: ghrelin (pg/mL)	Ghrelin (pg/mL) measured 10 minutes prior to protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T30)	Markers: ghrelin (pg/mL)	Ghrelin (pg/mL) measured 30 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T60)	Markers: ghrelin (pg/mL)	Ghrelin (pg/mL) measured 60 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T120)	Markers: ghrelin (pg/mL)	Ghrelin (pg/mL) measured 120 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on ghrelin levels (T180)	Markers: ghrelin (pg/mL)	Ghrelin (pg/mL) measured 180 minutes post protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T-10)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected immediately prior to protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T30)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected 30 minutes after protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T60)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected 60 minutes after protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T90)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected 90 minutes after protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T120)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected 120 minutes after protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T150)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected 150 minutes after protein shake consumption
Primary	To assess the acute effects of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO® on appetite (T180)	Subjective analysis including: Visual Analogue Scale for Appetite (VAS-A). Scores range from 0 to 100 (the higher the score the greater the level of appetite)	Visual Analogue Scale for Appetite (VAS-A) collected 180 minutes after protein shake consumption
Secondary	To assess the perception of Solanic®100, Oryzatein® Silk 90 and Instantized BiPRO®	Subjective analysis including: Visual Analogue Scale for Palatability (VAS-P). Scores range from 0 to 100 (the higher the score the lower the palatability)	VAS for Palatability collected immediately after protein shake consumption